Santhera Pharmaceuticals Holding AG Free Cash Flow for the year ending December 31, 2023: USD 27.95 M

Santhera Pharmaceuticals Holding AG Free Cash Flow is USD 27.95 M for the year ending December 31, 2023, a -176.46% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Santhera Pharmaceuticals Holding AG Free Cash Flow for the year ending December 31, 2022 was USD -36.55 M, a -10.78% change year over year.
  • Santhera Pharmaceuticals Holding AG Free Cash Flow for the year ending December 31, 2021 was USD -40.97 M, a -16.72% change year over year.
  • Santhera Pharmaceuticals Holding AG Free Cash Flow for the year ending December 31, 2020 was USD -49.19 M, a -2,113.87% change year over year.
  • Santhera Pharmaceuticals Holding AG Free Cash Flow for the year ending December 31, 2019 was USD 2.44 M, a -104.04% change year over year.
Key Data
Date Free Cash Flow Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities